TMS Co., Ltd. (JP:4891) has released an update. TMS Co., Ltd. has secured a U.S. patent for a new treatment for acute kidney injury using compounds including TMS-008, further strengthening its ...
MyChesCo on MSN2 个月
Neuronetics Expands TMS Coverage, Enhancing Access for MDD TreatmentMALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced significant progress in expanding access to its NeuroStar ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈